Cinacalcet Hydrochloride and Efavirenz, lamivudine, and tenofovir

• Generic Name: cinacalcet
• Dosage Forms: n.a.
• Other Brand Names: Sensipar

Treatment of secondary hyperparathyroidism associated with chronic renal disease in patients who are undergoing hemodialysis or peritoneal dialysis.

Safety and efficacy in patients who are not undergoing dialysis have not been established.

May be used alone or in conjunction with vitamin D analogs and/or phosphate binders.

Effects on clinical outcomes remain to be fully determined. The primary finding of the EVOLVE trial (a lack of effect on mortality or major cardiovascular events ) is controversial because of study limitations.

Management of hypercalcemia associated with parathyroid carcinoma; designated an orphan drug by FDA for this use.

Treatment of hypercalcemia associated with primary hyperparathyroidism in patients who would be candidates for parathyroidectomy based on serum calcium concentrations but who are unable to undergo the surgery; designated an orphan drug by FDA for this use.

• Generic Name: efavirenz / lamivudine / tenofovir
• Dosage Forms: n.a.
• Other Brand Names: Symfi, Symfi Lo

Efavirenz, lamivudine, and tenofovir is a combination antiviral medicine that is used to treat human immunodeficiency virus (HIV). HIV is the virus that can cause acquired immunodeficiency syndrome (AIDS). efavirenz, lamivudine, and tenofovir is not a cure for HIV or AIDS.

Symfi is for use in adults and children who weigh at least 88 pounds (40 kilograms).

Symfi Lo is for use in adults and children who weigh at least 77 pounds (35 kilograms).

Efavirenz, lamivudine, and tenofovir may also be used for purposes not listed in this medication guide.